R. Abraham
Senior Vice President,
Group Head of Oncology Rese Oncology
ASM
Italy
Biography
Robert (Bob) is Senior Vice President and Group Head, Oncology Research & Development Group. This group is at the forefront of breaking new ground to develop impactful, life-saving cancer therapies and spearheading the company’s Precision Medicine approach to Research and Development. Dr. Abraham also serves as the Director of the Pfizer Postdoctoral program, helping develop talented early career scientists into outstanding industry and academicDr. Abraham received his PhD in pharmacology at the University of Pittsburgh, and his BS in Biology from Bucknell University. He is the author of more than 200 scientific publications, and has served on and chaired grant review panels at the National Institutes of Health. He is a reviewer for many leading scientific journals, including Nature, Science, and Cell. Prior to this new role, Dr. Abraham served as Senior Vice President and Chief Scientific Officer of the Oncology Research Unit. Before joining Pfizer, Dr. Abraham was the Vice President of Oncology Research at Wyeth and Co-Chair of the Wyeth Oncology Therapeutic Area Strategic Committee. researchers.
Research Interest
Oncology,pharmacology,cell
